SolleviA, OstergrenJ, FagrellB, HjemdahlP.Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine. Acta Physiol Scand1984; 121: 165— 71.
SchwabeU, UkenaD, LohseMJ. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn-Schmiedebergs Arch Pharmacol1985; 330: 212— 21.
8.
GranatoJE, WatsonDD, BelardinelliL, CannonJM, BellerGA. Effects of dipyridamole and aminophylline on hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of critical coronary stenosis. J Am Coll Cardiol1990; 16: 1760— 70.
9.
SmitsP, BoekemaP, De AbreuR, ThienT, van'tLaar A. Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol1987; 10: 136— 43.
10.
SmitsP, StraatmanC, PijpersE, ThienT.Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine. Clin Pharmacol Ther1991; 50: 529— 37.
11.
SmitsP, HoffmannH, ThienT, HoubenH, van'tLaar A. Hemodynamic and humoral effects of coffee after β1-selective and nonselective β-blockade. Clin Pharmacol Ther1983; 34: 153— 8.
12.
SmithRV, WallerES, DoluisioJT, BauzaMT, PuriSK, HoI.Pharmacokinetics of orally administered pentoxifylline in humans. J Pharm Sei1986; 75: 47— 52.
13.
BeermannB, IngsR, MansbyJ, ChamberlainJ, McDonaldA.Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther1985; 37: 25— 8.
14.
RamesA, PoirierJM, LeCozF, MidavaineM, LecocqB, GrangeJD,. Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients. Clin Pharmacol Ther1990; 47: 354— 9.
15.
BrownKA, SlinkerBK. Pentoxifylline (Trental) does not inhibit dipyridamole-induced coronary hyperemia: implications for dipyridamole—thallium-201 myocardial imaging. J Nucl Med1990, 31: 1020— 4.
16.
BauerovaK, SoltesL, KallayZ, SchmidtovaK.Determination of pentoxifylline in serum by high-performance thin-layer chromatography. J Pharm Biomed Anal1991; 9: 247— 50.
